Anthropic is approaching a public valuation close to $1 trillion, potentially ranking it among the world's most valuable companies. However, investors are concerned because its revenue depends solely on AI products, unlike diversified giants like Samsung. While Anthropic's revenue could grow sevenfold in 2026, its lack of product diversification raises risks. The debate continues on whether AI companies like Anthropic and OpenAI are overvalued amid rapid AI growth and regulatory uncertainties.
Anthropic's valuation nearing $1 trillion is notable in global markets. For readers following the Technology sector, here is Pluang's market snapshot as of Sep 15, 2026 21:21 WIB: out of 150 priced US tech stocks, 50 rose and 96 fell. Notable price changes include CRSR at USD 13.58 (+4.22%), QCOM at USD 187.41 (+4.03%), and AXTI at USD 59.22 (+3.79%).
In Q3 2026, websites on Cloudflare's network blocked 13.47% of AI crawler requests, more than double the 5.98% blocked a year earlier. This rise in access denial affects how brands appear in AI-generated answers from platforms like ChatGPT, Gemini, a...
JPMorgan Asset Management (Canada) announced the final cash distributions for September 2026 for three of its ETFs traded on the Toronto Stock Exchange. Unitholders of record on October 19, 2026, will receive payments on October 23, 2026. The ETFs an...
Stillwater Critical Minerals Corp. has upgraded to the OTCQX Best Market from the OTCQB Venture Market, beginning trading under the symbol "PGEZF." This move enhances the company's visibility, liquidity, and accessibility to U.S. investors as it adva...
WasabiCard, a stablecoin-based global payment provider, engaged in key partnership discussions at TOKEN2049 Singapore 2026, focusing on white-label card issuing, global payouts, and embedded payments. The company highlighted growing demand in APAC fo...
The global next generation antibody therapeutics market is projected to increase from $5.45 billion in 2026 to $5.76 billion by 2035, growing at a CAGR of 1%. Growth is fueled by advances in biotechnology, rising demand for targeted therapies, and in...
